Comment on: “Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: the GeroCovid Study”
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Drugs & aging - 41(2024), 3 vom: 28. Feb., Seite 283-285 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kow, Chia Siang [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024 |
|---|
| doi: |
10.1007/s40266-024-01106-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055093752 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055093752 | ||
| 003 | DE-627 | ||
| 005 | 20240311095302.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240311s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40266-024-01106-z |2 doi | |
| 035 | |a (DE-627)SPR055093752 | ||
| 035 | |a (SPR)s40266-024-01106-z-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 15,3 |2 ssgn | ||
| 100 | 1 | |a Kow, Chia Siang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comment on: “Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: the GeroCovid Study” |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024 | ||
| 700 | 1 | |a Ramachandram, Dinesh Sangarran |4 aut | |
| 700 | 1 | |a Hasan, Syed Shahzad |4 aut | |
| 700 | 1 | |a Thiruchelvam, Kaeshaelya |0 (orcid)0000-0002-3754-1690 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs & aging |d Springer International Publishing, 1991 |g 41(2024), 3 vom: 28. Feb., Seite 283-285 |w (DE-627)SPR033224900 |w (DE-600)2043689-0 |x 1179-1969 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2024 |g number:3 |g day:28 |g month:02 |g pages:283-285 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s40266-024-01106-z |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2024 |e 3 |b 28 |c 02 |h 283-285 | ||